APRISO(TM) Granted FDA Marketing Approval for Maintenance of … WELT ONLINE, Germany - Oct 31, 2008 APRISO is a locally-acting aminosalicylate indicated for the maintenance of remission of ulcerative colitis (UC) in adults. APRISO is the first and only …

Tags: adults, aminosalicylate, apriso, fda approval, Remission, Uc, Ulcerative Colitis

This entry was posted on Monday, December 1st, 2008 at 9:18 am and is filed under Colon, bowel disease. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.